Michelson Medical Research Foundation, Inc.

LOS ANGELES, CA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$112.5M2026 Q3
Positions21
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.74.6%

Michelson Medical Research Foundation, Inc. reported 21 positions worth $112.5M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: AMRZ (13.3%).

10 / 21 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 AMRZAmrize$15.0M13.29%400,000——+8.4%
▸ 2 IVEiShares S&P 500$11.8M10.53%51,905——+5.0%
▸ 3 VEAVanguard Tax-Managed FDS$11.2M9.93%158,160———
▸ 4 ISRGIntuitive Surgical$8.5M7.59%21,000——+7.7%
▸ 5 VWOVanguard Intl Equity$7.6M6.73%127,630———
▸ 6 IBBIshares Tr$7.4M6.57%35,095———
▸ 7 CNNECannae$7.4M6.55%480,600——+13.9%
▸ 8 IWCIshares Tr$6.5M5.81%35,385———
▸ 9 KRESPDR Series$4.4M3.92%63,510——+4.0%
▸ 10 MANUManchester United$4.2M3.72%200,000——+6.0%

Pro Feature

The remaining 11 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Michelson Medical Research Foundation, Inc. hold as of Q3 2026?

Michelson Medical Research Foundation, Inc. reported 21 positions worth $112.5M in its Q3 2026 13F filing. Largest positions: AMRZ (13.3%), IVE (10.5%), VEA (9.9%), ISRG (7.6%) and VWO (6.7%).

What did Michelson Medical Research Foundation, Inc. buy in Q3 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Michelson Medical Research Foundation, Inc. sell in Q3 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.